378 related articles for article (PubMed ID: 25224616)
1. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
2. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment.
Quaife M; Eakle R; Cabrera M; Vickerman P; Tsepe M; Cianci F; Delany-Moretlwe S; Terris-Prestholt F
BMJ Open; 2016 Jun; 6(6):e010682. PubMed ID: 27354071
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
[TBL] [Abstract][Full Text] [Related]
4. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
5. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
[TBL] [Abstract][Full Text] [Related]
6. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
[TBL] [Abstract][Full Text] [Related]
7. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
[TBL] [Abstract][Full Text] [Related]
8. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
[TBL] [Abstract][Full Text] [Related]
9. Women and ARV-based HIV prevention - challenges and opportunities.
Geary CW; Bukusi EA
J Int AIDS Soc; 2014; 17(3 Suppl 2):19356. PubMed ID: 25224621
[TBL] [Abstract][Full Text] [Related]
10. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
Atujuna M; Newman PA; Wallace M; Eluhu M; Rubincam C; Brown B; Bekker LG
PLoS One; 2018; 13(2):e0191251. PubMed ID: 29420549
[TBL] [Abstract][Full Text] [Related]
11. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
12. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
[TBL] [Abstract][Full Text] [Related]
13. Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
Corneli A; Namey E; Ahmed K; Agot K; Skhosana J; Odhiambo J; Guest G
AIDS Patient Care STDS; 2015 Sep; 29(9):503-9. PubMed ID: 26196411
[TBL] [Abstract][Full Text] [Related]
14. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
[TBL] [Abstract][Full Text] [Related]
15. "It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa.
Fynn L; Gill K; Wallace M; Atujuna M; Duyver M; Ngcobo P; Spiegel H; Rinehart A; Hosek S; Bekker LG
BMC Public Health; 2023 Nov; 23(1):2143. PubMed ID: 37919697
[TBL] [Abstract][Full Text] [Related]
16. Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process.
Eakle R; Mutanha N; Mbogua J; Sibanyoni M; Bourne A; Gomez G; Venter F; Rees H
BMJ Open; 2018 Jun; 8(6):e019292. PubMed ID: 29903784
[TBL] [Abstract][Full Text] [Related]
17. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
Cholo FA; Dada S; Martin CE; Mullick S
J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
[TBL] [Abstract][Full Text] [Related]
18. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
[TBL] [Abstract][Full Text] [Related]
19. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
Eakle R; Bourne A; Mbogua J; Mutanha N; Rees H
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29457868
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
